Prenatal stem cells treat hemophilia A in preclinical study

by

Researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently published an article in Nature Communications that demonstrates the potential of bioengineered human placental cells as a cure for Hemophilia A.

Leave A Comment

Your email address will not be published. Required fields are marked *